Trials / Completed
CompletedNCT03562091
Perception of Information and Quality of Life in Neuroendocrine Tumour on Lanreotide Autogel
Observational Study on Perception of Information and Quality of Life in Neuroendocrine Tumor on Lanreotide Autogel
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 115 (actual)
- Sponsor
- Ipsen · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to evaluate, in standard practice, the change in information received and perceived by the patient, extension of the disease and its treatment. These parameters will be evaluated by means of validated self-administered questionnaires that can be used in standard practice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Data collection | The study is an observational evaluation that does not affect physician practices, the physician-patient relationship, or the care of subjects. The prescriptions will be decided prior to inclusion of the subject into the study. The information will be recorded using the data available in the medical file or collected during the visit (as part of the routine subject management). |
Timeline
- Start date
- 2018-07-20
- Primary completion
- 2020-05-15
- Completion
- 2020-05-15
- First posted
- 2018-06-19
- Last updated
- 2020-08-28
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03562091. Inclusion in this directory is not an endorsement.